Lunit, a leading medical AI provider, announced that the U.S. Food and Drug Administration (FDA) 510(k) has cleared its AI solution for breast cancer detection, Lunit INSIGHT MMG. Along with its chest X-ray triaging solution, Lunit INSIGHT CXR Triage, the company’s AI solution for both chest X-ray and mammography is now commercially available across the U.S.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now